-
Financial Statements
（605KB）
-
Supplement for the Financial Statements
（729KB）
|
Date |
May 19, 2026 |
|
Time |
10:00 ～ 11:00 |
|
Location |
Tokyo |
|
Attendeesfrom our company |
Mutsumi Kimura,President Kei Sato,Director Masakazu Usami,General Manager of Public Relations& Investor Relations Dept. Naoki Shibuya, President of Takara Shuzo Co., Ltd. Minori Mori, President of Takara Shuzo International Co., Ltd. Tsuyoshi Miyamura, President of Takara Bio Inc. |
-
Presentation Material
（938KB）
-
Presentation Material with notes
（1,639KB）
- On-Demand Streaming
-
Financial Statements
（357KB）
-
Supplement for the Financial Statements
（478KB）
-
Financial Results Briefing
（402KB）
-
Financial Statements
（426KB）
-
Supplement for the Financial Statements
（725KB）
|
Date |
November 13, 2025 |
|
Time |
11:05 ～ 12:00 |
|
Location |
Tokyo |
|
Attendeesfrom our company |
Mutsumi Kimura,President Kei Sato,Director Masakazu Usami,General Manager of Public Relations& Investor Relations Dept. |
-
Presentation Material
（1,425KB）
Regarding the financial results for the bio business, please note that our subsidiary, Takara Bio Inc. (listed on the Prime Market, code number 4974), held a financial results briefing on the same day. Please refer to that."
-
Financial Statements
（557KB）
-
Supplement for the Financial Statements
（705KB）
-
Financial Results Briefing
（462KB）
-
Financial Statements
（1,098KB）
-
Supplement for the Financial Statements
（818KB）
-
Annual Securities Report
（1,439KB）
|
Date |
May 15, 2025 |
|
Time |
11:05 ～ 12:00 |
|
Location |
Tokyo |
|
Attendeesfrom our company |
Mutsumi Kimura,President Hideo Takahashi,Managing Director Masakazu Usami,General Manager of Public Relations& Investor Relations Dept. |
-
Presentation Material
（2,052KB）
Regarding the financial results for the bio business, please note that our subsidiary, Takara Bio Inc. (listed on the Prime Market, code number 4974), held a financial results briefing on the same day. Please refer to that."
-
Financial Statements
（854KB）
-
Supplement for the Financial Statements
（915KB）
-
Financial Results Briefing
（1,512KB）
-
Financial Statements
（829KB）
-
Supplement for the Financial Statements
（703KB）
|
Date |
November 12, 2024 |
|
Time |
11:05 ～ 12:00 |
|
Location |
Tokyo |
|
Attendeesfrom our company |
Mutsumi Kimura,President Hideo Takahashi,Managing Director Masakazu Usami,General Manager of Public Relations& Investor Relations Dept. |
-
Presentation Material
（2,429KB）
Regarding the financial results for the bio business, please note that our subsidiary, Takara Bio Inc. (listed on the Prime Market, code number 4974), held a financial results briefing on the same day. Please refer to that."
-
Financial Statements
（843KB）
-
Supplement for the Financial Statements
（632KB）
-
Financial Results Briefing
（635KB）
-
Financial Statements
（934KB）
-
Supplement for the Financial Statements
（827KB）
-
Annual Securities Report
（1,328KB）
|
Date |
May 14 , 2024 |
|
Time |
11:05 ～ 12:00 |
|
Location |
Tokyo |
|
Attendeesfrom our company |
Mutsumi Kimura,President Hideo Takahashi,Managing Director Masakazu Usami,General Manager of Public Relations& Investor Relations Dept. |
-
Presentation Material
（2,678KB）
Regarding the financial results for the bio business, please note that our subsidiary, Takara Bio Inc. (listed on the Prime Market, code number 4974), held a financial results briefing on the same day. Please refer to that."
-
Financial Statements
（796KB）
-
Supplement for the Financial Statements
（628KB）
-
Financial Statements
（943KB）
-
Supplement for the Financial Statements
（825KB）
|
Date |
Nov 14 , 2023 |
|
Time |
11:10 ～ 12:00 |
|
Location |
Tokyo |
|
Attendees from our company |
Mutsumi Kimura,President Hideo Takahashi,Managing Director Masakazu Usami,General Manager of Public Relations& Investor Relations Dept. |
-
Presentation Material
（3,544KB）
Regarding the financial results for the bio business, please note that our subsidiary, Takara Bio Inc. (listed on the Prime Market, code number 4974), held a financial results briefing on the same day. Please refer to that."
-
Financial Statements
（867KB）
-
Supplement for the Financial Statements
（605KB）
-
Financial Statements
（760KB）
-
Supplement for the Financial Statements
（805KB）
|
Date |
May 16 , 2023 |
|
Time |
11:10 ～ 12:00 |
|
Location |
Tokyo |
|
Attendees from our company |
Mutsumi Kimura,President Hideo Takahashi,Managing Director Masakazu Usami,General Manager of Public Relations& Investor Relations Dept. |
-
Presentation Material
（2,297KB）
Regarding the financial results for the bio business, please note that our subsidiary, Takara Bio Inc. (listed on the Prime Market, code number 4974), held a financial results briefing on the same day. Please refer to that."
-
Financial Statements
（716KB）
-
Supplement for the Financial Statements
（718KB）
-
Financial Statements
（815KB）
-
Supplement for the Financial Statements
（807KB）
|
Date |
November 15, 2024 |
|
Time |
11:10 ～ 12:00 |
|
Location |
Tokyo |
|
Attendees from our company |
Mutsumi Kimura,President Keisuke Mori, Director Masakazu Usami,General Manager of Public Relations& Investor Relations Dept. |
-
Presentation Material
（4,508KB）
Regarding the financial results for the bio business, please note that our subsidiary, Takara Bio Inc. (listed on the Prime Market, code number 4974), held a financial results briefing on the same day. Please refer to that."
-
Financial Statements
（758KB）
-
Supplement for the Financial Statements
（712KB）